THE COST-EFFECTIVENESS OF RISPERIDONE LONG-ACTING INJECTION IN SCHIZOPHRENIA TREATMENT: A SYSTEMATIC REVIEW

被引：0
|
作者：
Li, H. [1 ]
Ren, J. [1 ]
Yu, X. [2 ]
机构：
[1] China Pharmaceut Univ, Nanjing, Jiangsu, Peoples R China
[2] Xian Janssen Pharmaceut Ltd, Beijing, Peoples R China
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A670 / A670
页数：1
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF PASIREOTIDE LONG-ACTING RELEASE IN ACROMEGALY: SYSTEMATIC LITERATURE REVIEW
    Binowski, G.
    Schmidt, F.
    Bronikowska, M.
    Jachimowicz, M.
    Gilis-Januszewska, A.
    VALUE IN HEALTH, 2024, 27 (12) : S66 - S66
  • [32] Cost-Effectiveness of Olanzapine Long-Acting Injection in the Treatment of Non-Adherent Patients with Schizophrenia in the United States
    Ascher-Svanum, H.
    Furiak, N. M.
    Klein, R. W.
    Montgomery, W.
    Smolen, L. J.
    Lawson, A. H.
    Conley, R. R.
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2009, 12 : S4 - S4
  • [33] Long-acting injectable risperidone for the treatment of schizophrenia
    Moeller, Hans-Juergen
    DRUGS, 2007, 67 (11) : 1541 - 1566
  • [34] Risperidone long-acting injection: A systematic review of UK naturalistic studies
    Patel, MX
    Young, C
    Taylor, DM
    David, AS
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A15 - A15
  • [35] Risperidone long-acting injection: a systematic review of UK naturalistic studies
    Patel, MX
    Young, C
    Taylor, DM
    David, AS
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S462 - S462
  • [36] Cost-effectiveness and budget impact of long-acting risperidone in Portugal: a modeling exercise
    Heeg, B. M. S.
    Antunes, J.
    Figueira, M. L.
    Jara, J. M.
    Teixeira, J. Marques
    Palha, A. P.
    Serra, A. Vaz
    Buskens, E.
    Caleo, S.
    Gouveia-Pinto, C.
    Van Hout, B. A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (02) : 349 - 358
  • [37] COST-EFFECTIVENESS OF RISPERIDONE LONG-ACTING INJECTABLE VERSUS QUETIAPINE IN SCHIZOPHRENIC PATIENTS
    Elkis, H.
    Pereira, M.
    Kayo, M.
    Duchesne, I
    Alandete, J. C.
    VALUE IN HEALTH, 2009, 12 (07) : A521 - A521
  • [38] Effectiveness of risperidone long-acting injection in first-episode schizophrenia: In naturalistic setting
    Kim, Borah
    Lee, Sang-Hyuk
    Choi, Tae Kyou
    Suh, ShinYoung
    Kim, Yong Woo
    Lee, EunHee
    Yook, Ki Hwan
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (05): : 1231 - 1235
  • [39] Long-acting risperidone injection
    Love, RC
    Conley, RJ
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (17) : 1792 - 1800
  • [40] Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain
    Javier Quintero
    Itziar Oyagüez
    Beatriz González
    Ignacio Cuervo-Arango
    Ignacio García
    Miguel Angel Casado
    Clinical Drug Investigation, 2016, 36 : 479 - 490
12345